Acquired Immune Deficiency Syndrome
2
Pipeline Programs
5
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
2
Early DiscoveryClinical DevelopmentMarket
Drug Modality Breakdown
Small Molecule
2100%
+ 3 programs with unclassified modality
Competitive Landscape
5 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
UNION therapeuticsfirst line ARV
Kite PharmaLopinavir 400 mg/ritonavir 100 mg
MSDRaltegravir
Clinical Trials (3)
Total enrollment: 825 patients across 3 trials
Study on the Antiviral Therapy and Immune Reconstitution of Chinese HIV/AIDS Patients
Start: Mar 2009Est. completion: Dec 2010750 patients
Phase 4Unknown
Immune Reconstitution of Lopinavir/Ritonavir-Based vs Efavirenz-based HAART in Advanced HIV Disease
Start: Oct 2008Est. completion: Jan 201115 patients
Phase 4Terminated
Pilot Study of a Raltegravir Based NRTI Sparing Regimen
Start: May 2009Est. completion: Nov 201360 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
5 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.